Menu

Welcome to

Nordic Society of Gynaecological Oncology

Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M) in Combination Therapy for Ovarian Cancer
-Study to be conducted at multiple sites across Europe through European Network of Gynaecological Oncological Trial groups (ENGOT)

Registration for NSGO Virtual Annual Meeting 10-12 March 2021 is closed.

Already registered for NSGO Annual Meeting 2021 – how to acces the recorded sessions read more HERE

 

Thank you for an Excellent NSGO-CTU Investigator Meeting 26 - 27 November 2020

We are looking forward to welcome you this year in
Copenhagen, Denmark from 25-26 November to NSGO-CTU Biannual Investigator Meeting 2021

A warm welcome to our two new Deputy Medical Directors:

Kristina Lindemann (Radiumhospital, Oslo)   &
Kristine Madsen (Rigshospitalet, Copenhagen)


SEE THE NEW RESULTS OF THE CERVIX BT PLANNING MRI SURVEY,

CLICK HERE

ENGOT-EN3 / NSGO-PALEO
study results presented
at ESMO 2020

Mansoor Raza Mirza, Medical Director of NSGO-CTU, presented very exciting results from the ENGOT-EN3/NSGO-PALEO trial at 2020 ESMO Virtual Congress 2020.